Mapping Catheters market research report by Delvens focuses on primary sections such as – market segments, market outlook, competitive landscape, and company profiles. The segments provide details in terms of various perspectives such as end-use industry, product or service type, and any other relevant segmentation as per the market’s current scenario which includes various aspects to perform further marketing activity.
The global Mapping Catheters market size was estimated at USD 3.07 billion in 2023 and is projected to reach USD 5.46 billion in 2030 at a CAGR of 8.60% during the forecast period 2023-2030.
Get Free Sample Report: https://www.delvens.com/get-free-sample/mapping-catheters-market
Mapping Catheters are thin, flexible tubes that are inserted into the heart through a vein in the leg. They are used to map electrical activity of the heart, which can be used to identify the source of an arrhythmia. Mapping catheters are of two types – contact mapping catheters and non-contact mapping catheters. Contact mapping catheters are the most common type. They have electrodes that touch the heart tissue, which allows them to record the electrical activity of the heart. Non-contact mapping catheters use magnetic fields or ultrasound to record the electrical activity of the heath without touching the heart tissue.
Mapping catheters are used in a variety of procedures such as atrial fibrillation ablation, atrial flutter ablation, ventricular tachycardia ablation, ventricular fibrillation ablation, etc. They are a valuable tool for the diagnosis and treatment of arrhythmias. They allow doctors to see exactly where in the heart the arrhythmia is coming from, which helps them to choose the best treatment.
Regional Analysis
North America to Dominate the Market
North America is estimated to account for the largest market share during the forecast period. This is due to the high prevalence of cardiovascular diseases in North America.
The increasing demand for minimally invasive procedures, and the presence of major players in the region will further increase the market growth during the forecast period.
Competitive Landscape
- Acutus Medical Inc.
- Koninklijke Philips
- MicroPort Scientific Corporation
- EPMap Systems
- Kardium Inc.
- APN Healthcare
- Boston Bioscientific Corporation
- Lepu Medical Technology
- Abbott Laboratories
- Medtronic Plc.
- BioSig Technologies
- Johnson and Johnson (Biosense Webster)
- AngioDynamics
- Catheter Precision, Inc. and More
For More Inquiry Contact us: https://www.delvens.com/Inquire-before-buying/mapping-catheters-market
Recent Developments
In 2022, Biosense Webster, Inc, introduced the ‘OCTARAY’ mapping catheter based on ‘TRUEref’ technology, which is powered by the CARTO 3 Version 7 system. The catheter was developed for mapping cardiac arrhthmias, including atrial fibrillation.
In 2021, Medtronic launched the new generation of drug coated balloon (DCB) catheter in Europe which is used to treat coronary heart diseases.
Table of Contents
The Global Mapping Catheters Market is segmented into various segments such as Type, Indication, End User and region:
Based on Type
- Contact Mapping Catheters
- Non-Contact Mapping Catheters
Based on the Indication
- Atrial fibrillation ablation
- Atrial flutter ablation
- Ventricular tachycardia ablation
- Ventricular fibrillation ablation
Based on the End User
- Hospital
- Clinics
- Research Laboratories
- Others
Access Full Report: https://www.delvens.com/report/mapping-catheters-market
In addition to the market data for the Global Mapping Catheters Market, Delvens offers client-centric reports customized according to the company’s specific demand and requirements.
Reasons to Acquire
Increase your understanding of the market for identifying the most suitable strategies and decisions based on sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors.
Gain authentic and granular data access for the Global Mapping Catheters Market to understand the trends and the factors involved in changing market situations.
Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future.
In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns.
More Reports from Delvens:
Pendred Syndrome (PS) market size was estimated at USD 2.82 billion in 2023 and is projected to reach USD 3.83 billion in 2030 at a CAGR of 4.5% during the forecast period 2023-2030.
Multiple Sclerosis (MS) market size was estimated at USD 25.2 billion in 2023 and is projected to reach USD 34.9 billion in 2030 at a CAGR of 4.76% during the forecast period 2023-2030.
Plastic Surgery and Integumentary System Market size was estimated at USD 3.02 billion in 2023 and is projected to reach USD 4.3 billion in 2030 at a CAGR of 5.2% during the forecast period 2023-2030.
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT Telecom, Chemicals Materials, Semiconductor Electronics, Energy, Pharmaceutical, Consumer Goods Services, Food Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-3290-6466
+1 214-377-1144
